Report

Global Cell and Gene Therapy Manufacturing Market Size study, by Type (Cell Therapy Manufacturing (Stem Cell Therapy, Non-Stem Cell Therapy )Gene Therapy Manufacturing) by Scale (Pre-commercial/ R&D Scale Manufacturing, Commercial Scale Manufacturing ), by Mode (Contract Manufacturing, In-house Manufacturing), by workflow (Cell Processing, Cell Banking, Process Development, Fill & Finish Operations, Analytical And Quality Testing, Raw Material Testing, Vector Production, Others) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Cell and Gene Therapy Manufacturing Market , by Region, 2019-2027 (USD Billion)
1.2.2. Cell and Gene Therapy Manufacturing Market , by Type, 2019-2027 (USD Billion)
1.2.3. Cell and Gene Therapy Manufacturing Market , by Scale , 2019-2027 (USD Billion)

1.2.4. Cell and Gene Therapy Manufacturing Market , by Mode, 2019-2027 (USD Billion)

1.2.5. Cell and Gene Therapy Manufacturing Market, by Workflow, 2019-2027 (USD Billion)

1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell and Gene Therapy Manufacturing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell and Gene Therapy Manufacturing Market Dynamics
3.1. Cell and Gene Therapy Manufacturing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing pipeline of cell and Gene therapy
3.1.1.2. Supportive regulatory bodies
3.1.2. Market Restraint
3.1.2.1. Technological challenges associated with manufacturing
3.1.2.2. High cost of manufacturing
3.1.3. Market Opportunities
3.1.3.1. Rising pressure on drug developers/manufacturers to meet growing market demand
Chapter 4. Global Cell and Gene Therapy Manufacturing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell and Gene Therapy Manufacturing Market , by Type
5.1. Market Snapshot
5.2. Global Cell and Gene Therapy Manufacturing Market by Type , Performance - Potential Analysis
5.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
5.4.1. Cell Therapy Manufacturing
5.4.1.1. Stem Cell Therapy
5.4.1.2. Non-Stem Cell Therapy
5.4.2. Gene Therapy Manufacturing


Chapter 6. Global Aniline Derivative Market, By Scale

6.1. Market Snapshot
6.2. Global Cell and Gene Therapy Manufacturing Market by Scale, Performance - Potential Analysis
6.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Scale 2018-2027 (USD Billion)
6.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
6.4.1. Pre-commercial/ R&D Scale Manufacturing
6.4.2. Commercial Scale Manufacturing


Chapter 7. Global Cell and Gene Therapy Manufacturing Market , by Mode
7.1. Market Snapshot
7.2. Global Bot Global Cell and Gene Therapy Manufacturing Market by Mode Performance - Potential Analysis
7.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Mode 2018-2027 (USD Billion)
7.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
7.4.1. Contract Manufacturing
7.4.2. In-house Manufacturing

Chapter 8. Global Cell and Gene Therapy Manufacturing Market, By Workflow
8.1. 8.1 Market Snapshot
8.2. Global Bot Global Cell and Gene Therapy Manufacturing Market by Workflow Performance - Potential Analysis
8.3. Global Cell and Gene Therapy Manufacturing Market Estimates & Forecasts by Workflow 2018-2027 (USD Billion)
8.4. Cell and Gene Therapy Manufacturing Market , Sub Segment Analysis
8.4.1. Cell Processing
8.4.2. Cell Banking
8.4.3. Process Development
8.4.4. Fill & Finish Operations
8.4.5. Analytical And Quality Testing
8.4.6. Raw Material Testing
8.4.7. Vector Production
8.4.8. Others

Chapter 9. Global Cell and Gene Therapy Manufacturing Market , Regional Analysis
9.1. Cell and Gene Therapy Manufacturing Market , Regional Market Snapshot
9.2. North America Cell and Gene Therapy Manufacturing Market
9.2.1. U.S. Cell and Gene Therapy Manufacturing Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Application breakdown estimates & forecasts, 2018-2027
9.2.1.3. End use breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell and Gene Therapy Manufacturing Market
9.3. Europe Cell and Gene Therapy Manufacturing Market Snapshot
9.3.1. U.K. Cell and Gene Therapy Manufacturing Market
9.3.2. Germany Cell and Gene Therapy Manufacturing Market
9.3.3. France Cell and Gene Therapy Manufacturing Market
9.3.4. Spain Cell and Gene Therapy Manufacturing Market
9.3.5. Italy Cell and Gene Therapy Manufacturing Market
9.3.6. Rest of Europe Cell and Gene Therapy Manufacturing Market
9.4. Asia-Pacific Cell and Gene Therapy Manufacturing Market Snapshot
9.4.1. China Cell and Gene Therapy Manufacturing Market
9.4.2. India Cell and Gene Therapy Manufacturing Market
9.4.3. Japan Cell and Gene Therapy Manufacturing Market
9.4.4. Australia Cell and Gene Therapy Manufacturing Market
9.4.5. South Korea Cell and Gene Therapy Manufacturing Market
9.4.6. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market
9.5. Latin America Cell and Gene Therapy Manufacturing Market Snapshot
9.5.1. Brazil Cell and Gene Therapy Manufacturing Market
9.5.2. Mexico Cell and Gene Therapy Manufacturing Market
9.6. Rest of The World Cell and Gene Therapy Manufacturing Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Lonza
10.2.4. Catalent Inc.
10.2.5. Takara Bio Inc.
10.2.6. F. Hoffmann-La Roche Ltd
10.2.7. Wuxi Advanced Therapies
10.2.8. Samsung Biologics
10.2.9. Boehringer Ingelheim
10.2.10. Novartis AG
Chapter 11. Research Application
11.1. Research Application
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption